GAMMA Investing’s NeoGenomics NEO Stock Holding History
Bought
Maintained
Sold
Other funds holding NEO
MNBTD
VCM
FFA
MGI
MPWT
GBT
GWM
DCM
GAMMA Investing's NEO Position: Q3 2026 in Review
GAMMA Investing increased its NeoGenomics (NEO) stake by 30% in Q3 2026, buying an estimated $10.6K and bringing the position to 2,782 shares worth $51.1K. The position accounts for ﹤0.01% of the portfolio, ranked #2354.
GAMMA Investing first reported a position in NEO in Q4 2023 and has held it in 12 quarters since. 9 funds tracked by Wall St. Rank hold NEO as of Q3 2026.
- GAMMA Investing held 2,782 shares of NeoGenomics worth $51.1K as of Q3 2026.
- GAMMA Investing bought 644 NeoGenomics shares in Q3 2026, an estimated $10.6K.
- NeoGenomics made up ﹤0.01% of GAMMA Investing's portfolio in Q3 2026, its #2354 holding.
- GAMMA Investing first reported a position in NeoGenomics in Q4 2023 and has held it in 12 quarters since.
- 9 funds tracked by Wall St. Rank held NeoGenomics as of Q3 2026.
Based on GAMMA Investing's 13F filing for Q3 2026, filed 8 Oct 2026.